Carisma Therapeutics Inc Share Price Today: Live Updates & Key Insights
Carisma Therapeutics Inc share price today is $0.118, up -43.81%. The stock opened at $0.158 against the previous close of $0.2739, with an intraday high of $0.17 and low of $0.147.
Carisma Therapeutics Inc Share Price Chart
Carisma Therapeutics Inc
Carisma Therapeutics Inc Share Price Performance
Carisma Therapeutics Inc Institutional Holdings
Carisma Therapeutics Inc Market Status
Carisma Therapeutics Inc Fundamentals
Market Cap 11.45 M
PB Ratio 114.0987
PE Ratio 0.0
Enterprise Value 10.98 M
Total Assets 30.46 M
Volume 15421470
Carisma Therapeutics Inc Company Financials
About Carisma Therapeutics Inc & investment objective
Company Information Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Organisation Biotechnology
Employees 46
Industry Biotechnology
CEO Mr. Steven Kelly
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Carisma Therapeutics Inc FAQs
What is the share price of Carisma Therapeutics Inc today?
The current share price of Carisma Therapeutics Inc is $0.118.
Can I buy Carisma Therapeutics Inc shares in India?
Yes, Indian investors can buy Carisma Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Carisma Therapeutics Inc shares in India?
You can easily invest in Carisma Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Carisma Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Carisma Therapeutics Inc.
Can I buy fractional shares of Carisma Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Carisma Therapeutics Inc?
Carisma Therapeutics Inc has a market cap of $11.45 M.
In which sector does Carisma Therapeutics Inc belong?
Carisma Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Carisma Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Carisma Therapeutics Inc?
The PE ratio of Carisma Therapeutics Inc is N/A and the PB ratio is 114.10.